Testosterone / working resource

Clinical conversation planner

Bring specific questions and a source record to a qualified clinician.

Start with the product-specific question

How low testosterone is diagnosed

Testosterone replacement, with the evidence and its limits in plain view. What should I know about how low testosterone is diagnosed?

In TRAVERSE, the primary endpoint (cardiovascular death, nonfatal heart attack or nonfatal stroke) occurred in 7.0% on testosterone and 7.3% on placebo (hazard ratio 0.96, 95% CI 0.78 to 1.17), meeting noninferiority; mean treatment was 21.7 months and mean follow-up 33.0 months.
Read the original record ↗

Open the Testosterone library ↗

Choose the questions that need an answer.

Use the Testosterone research to prepare a conversation, then let the clinician assess your individual situation. This worksheet does not determine eligibility or treatment.

What should I know about how low testosterone is diagnosed?What should I know about what the TRAVERSE trial found?What should I know about blood tests while on treatment?Which evidence applies to the exact Testosterone formulation being considered?What alternatives address the same goal, and what evidence supports them?Which risks, interactions and uncertainties matter for this decision?What would count as a useful outcome, and when would it be reassessed?Who should I contact if I have a problem or an unresolved question?The specific goal or uncertainty I want to discuss

Your conversation agenda

Select questions above to create your agenda here.

Source URLs and product documents to bringAnswers, unresolved points and agreed follow-up

Share personal health details only through your care provider's appropriate private channel. This page does not send or save your notes.

These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.

Explore all six resources ↗